BioSpace News Archive

The milestone payment relates to the commercial launch and reimbursement in Germany of FOTIVDA® as a first line treatment of adult patients with advanced renal cell carcinoma

First Clinical Trial of a Program Designed to Address Multiple Brain Pathologies in Alzheimer’s Disease by Reversing Immune Dysfunction

NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH).

Premier Health Group is pleased to announce that as a part of its expansion plans, Premier Health will enter the Cannabis clinic space by a series of acquisitions, partnerships and/or launching a new Canada-based chain in the first half of 2019.

Drug Development Approach Combines twoXAR’s Artificial Intelligence-Driven Discovery Technology with the Adynxx Team’s Development Experience

Mr. Cumbo, biotech industry veteran, brings commercial expertise and strategic leadership in industry-leading commercial product launches

Will 2020 be the year for Alzheimer’s disease? Yes, says Hevilo Life Sciences, which is on track to meet this goal with the announcement of early access to NE-ALZ-138 – a targeted polytherapeutic solution which to date has proven effective in reducing the risk of developing Alzheimer’s disease, and managing, delaying progression and reversing the impacts of the disease.

Reza M. Haque, MD, PhD, has been appointed as Senior Vice President, Global Research and Development Strategy, and Peter Sallstig, MD, MBA, has been appointed as Senior Vice President, Global Product Development.

Flagship Pioneering today announced the recipient of the firm’s annual Pioneering Leader Award.

-- In its continuing commitment to expand work-based learning and externship opportunities for students, CVS Health has announced a new collaboration with Philadelphia Job Corps, Philadelphia Works and Philadelphia Youth Network